Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FJK8A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,472
Award facts
- Contract value 100% obligated
- $69,471.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,471.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Jardiance 10 mg tablets in quantities of 90 units. The contract, which carries no set-aside designation, is set to be completed by January 30, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical through December 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to military healthcare systems globally.
AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly supporting military and veteran healthcare systems through the DLA supply chain. The Jardiance supply under this order supports diabetes management across Department of Defense and other federal healthcare programs. As a competitively awarded contract with firm fixed pricing, this delivery order exemplifies the contractor's established capability to efficiently fulfill federal procurement requirements for essential pharmaceutical products across multiple therapeutic domains, leveraging its comprehensive parent company IDC framework to ensure reliable supply chain support.
Quick answers
Who was awarded contract SPE2DR26FJK8A?
SPE2DR26FJK8A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FJK8A worth?
The government has obligated $69,472 on SPE2DR26FJK8A.
Is contract SPE2DR26FJK8A an order under another contract?
Yes. SPE2DR26FJK8A is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK8A competed?
The extent of competition for SPE2DR26FJK8A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award